The promise of stem cell therapy to restore urethral sphincter function

Current Urology Reports

Volumn 8, Issue 5, 2007, Pages 373-378

  Furuta, Akira ^b   Jankowski, Ron J ^b   Pruchnic, Ryan ^b   Yoshimura, Naoki ^b   Chancellor, Michael B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; IMIPRAMINE;

BLADDER FUNCTION; BLADDER SPHINCTER; BONE MARROW CELL; CELL STRUCTURE; HUMAN; PELVIC FLOOR MUSCLE TRAINING; REVIEW; STEM CELL TRANSPLANTATION; STRESS INCONTINENCE;

ADULT STEM CELLS; CLINICAL TRIALS AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; URINARY INCONTINENCE; UROLOGIC SURGICAL PROCEDURES;

EID: 34848833513     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-007-0034-4     Document Type: Review

References (44)

1. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S: A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol 2000, 53:1150-1157.
2. Bump RC, Norton PA: Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 1998, 25:723-746.
3. Sampselle CM, Miller JM, Mims BL, et al.: Effect of pelvic muscle exercise on transient incontinence during pregnancy and after birth. Obstet Gynecol 1998, 91:406-412.
4. McGuire EJ, Lytton B, Pepe V, Kohorn EI: Stress urinary incontinence. Obstet Gynecol 1976, 47:255-264.
5. Blaivas JG: A modest proposal for the diagnosis and treatment of urinary incontinence in women. J Urol 1987, 138:597-598.
6. Kayigil O, Iftekhar Ahmed S, Metin A: The coexistence of intrinsic sphincter deficiency with type II stress incontinence. J Urol 1999, 162:1365-1366.
7. Chancellor M: Duloxetine for treatment of stress urinary incontinence. Evidence Based OBGYN 2004, 6:196-199.
8. Nygaard I: Prevention of exercise incontinence with mechanical devices. J Reprod Med 1995, 40:89-94.
9. Bent AE, Tutrone RT, McLennan MT, et al.: Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol Urodyn 2001, 20:157-165.
10. Ulmsten U, Johnson P, Rezapour M: A three-year follow up of tension free vaginal tape for surgical treatment of female stress urinary incontinence. Br J Obstet Gynaecol 1999, 106:345-350.
11. Nilsson CG, Kuuva N, Falconer C, et al.: Long-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2001, 12(Suppl 2):5-8.
12. Jeffry L, Deval B, Birsan A, et al.: Objective and subjective cure rates after tension-free vaginal tape for treatment of urinary incontinence. Urology 2001, 58:702-706.
13. Ward KL, Hilton P: A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up. Am J Obstet Gynecol 2004, 190:324-331.
14. Lee JY, Cannon TW, Pruchnic R, et al.: The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2003, 14:31-37.
15. Pittenger MF, Mackay AM, Beck SC, et al.: Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
16. Ferrari G, Cusella-De Angelis G, Coletta M, et al.: Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998, 279:1528-1530.
17. Dezawa M, Ishikawa H, Itokazu Y, et al.: Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005, 309:314-317.
18. Qu Z, Balkir L, van Deutekom JC, et al.: Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 1998, 142:1257-1267.
19. Jankowski RJ, Deasy BM, Huard J: Muscle-derived stem cells. Gene Ther 2002, 9:642-647.
20. Oshima H, Payne TR, Urish KL, et al.: Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 2005, 12:1130-1141.
21. Lee JY, Qu-Petersen Z, Cao B, et al.: Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 2000, 150:1085-1100.
22. Qu Z, Deasy B, Jankowski R, et al.: Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002, 157:851-864.
23. Yokoyama T, Yoshimura N, Dhir R, et al.: Persistence and survival of autologous muscle derived cells versus bovine collagen as potential treatment of stress urinary incontinence. J Urol 2001, 165:271-276.
24. Lee JY, Paik SY, Yuk SH, et al.: Long term effects of muscle-derived stem cells on leak point pressure and closing pressure in rats with transected pudendal nerves. Mol Cells 2004, 18:309-313. Most long-term effects of MDSCs on leak point pressures compared with collagen.
25. Kwon D, Kim Y, Pruchnic R, et al.: Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence. Urology 2006, 68:449-454. Safety and efficacy of pure MDSC injection therapy for the treatment of stress urinary incontinence compared with fibroblasts.
26. Chancellor MB, Yokoyama T, Tirney S, et al.: Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility. Neurourol Urodyn 2000, 19:279-287.
27. Yokoyama T, Pruchnic R, Lee JY, et al.: Autologous primary muscle-derived cells transfer into the lower urinary tract. Tissue Eng 2001, 7:395-404.
28. Huard J, Yokoyama T, Pruchnic R, et al.: Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction. Gene Ther 2002, 9:1617-1626.
29. Cannon TW, Lee JY, Somogyi G, et al.: Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra. Urology 2003, 62:958-963.
30. Chermansky CJ, Tarin T, Kwon DD, et al.: Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology 2004, 63:780-785.
31. Zuk PA, Zhu M, Mizuno H, et al.: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
32. Rodriguez LV, Alfonso Z, Zhang R, et al.: Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cells. Proc Natl Acad Sci U S A 2006, 103:12167-12172.
33. Jack GS, Almeida FG, Zhang R, et al.: Processed lipoaspirate cells for tissue engineering of the lower urinary tract: implications for the treatment of stress urinary incontinence and bladder reconstruction. J Urol 2005, 174:2041-2045.
34. Zeng X, Jack GS, Zhang R, et al.: Treatment of SUI using adipose derived stem cells: restoration of urethral function [abstract]. J Urol 2006, 175:291.
35. DeLancey JO: Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol 1994, 170:1713-1720; 1720-1723.
36. Kamo I, Torimoto K, Chancellor MB, et al.: Urethral closure mechanisms under sneeze-induced stress condition in rats: a new animal model for evaluation of stress urinary incontinence. Am J Physiol Regul Integr Comp Physiol 2003, 285:R356-R365. Active urethral closure mechanism under sneezing in the middle urethra regardless of the passive transmission of intra-abdominal pressure.
37. Kamo I, Kaiho Y, Canon TW, et al.: Functional analysis of active urethral closure mechanisms under sneeze induced stress condition in a rat model of birth trauma. J Urol 2006, 176:2711-2715.
38. Kamo I, Cannon TW, Conway DA, et al.: The role of bladder-to-urethral reflexes in urinary continence mechanisms in rats. Am J Physiol Renal Physiol 2004, 287:F434-F441.
39. Thor KB, Katofiasc MA: Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther 1995, 274:1014-1024.
40. Chancellor MB, Perkin H, Yoshimura N: Recent advances in the neurophysiology of stress urinary incontinence. Scand J Urol Nephrol 2005, 39:21-24.
41. Kaiho Y, Kamo I, Chancellor MB, et al.: Role of noradrenergic pathways in sneeze-induced urethral continence reflex in rats. Am J Physiol Renal Physiol 2007, 292:F639-F646. This is the first report that examines the contribution of spinal noradrenergic descending pathways in urinary continence during sneezing.
42. Strasser H, Tiefenthaler M, Steinlechner M, et al.: Age dependent apoptosis and loss of rhabdosphincter cells. J Urol 2000, 164:1781-1785.
43. Strasser H, Marksteiner R, Margreiter E, et al.: Transurethral ultrasound guided stem cell therapy of urinary incontinence [abstract]. J Urol 2006, 175:291.
44. Carr LK, Steele D, Steele S, et al.: Single institution clinical trial of muscle-derived cell injection to treat stress urinary incontinence [abstract]. J Urol 2006, 175:414.